Skip to main content
Clinical Trials/NCT01171235
NCT01171235
Unknown
Not Applicable

Study of Previously Collected Blood and Tissue Samples From Patients With Nasopharyngeal Carcinoma,Laryngeal Carcinoma and Hypopharyngeal Carcinoma

Southern Medical University, China0 sites200 target enrollmentJuly 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Laryngeal Neoplasms
Sponsor
Southern Medical University, China
Enrollment
200
Last Updated
15 years ago

Overview

Brief Summary

The aim of the study is to find for one or more serum or tissue markers of molecular biology in head and neck cancer patients used for early diagnosis, predicting prognosis and being sensitive to chemotherapy and radiotherapy

Detailed Description

Head and neck malignant tumors, especially nasopharyngeal carcinoma in southern China with the high incidence, its incidence, treatment, prognosis or tumor markers in serum has been a hot research with little progress.In our study, we collect NPC-based collection including the blood samples of laryngeal, hypopharyngeal cancer, separating serum and white blood cells stored in -80 degrees,while tissues are frozen in liquid nitrogen and embedded in paraffin。 Patient treatment and prognosis are combined in order to find for markers of molecular biology used for early diagnosis, predicting prognosis and being sensitive to chemotherapy and radiotherapy.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
December 2012
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Southern Medical University, China

Eligibility Criteria

Inclusion Criteria

  • all of nasopharyngeal carcinoma
  • hypopharyngeal carcinoma or laryngeal carcinoma visited at ENT department of NanFang hospital

Exclusion Criteria

  • all of above patients whose anticipated survival duration were less than 6 months

Outcomes

Primary Outcomes

Not specified

Similar Trials